Nervgen Pharma Corp Stock Price History
NGENF Stock | USD 1.96 0.01 0.51% |
If you're considering investing in NervGen OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of NervGen Pharma stands at 1.96, as last reported on the 31st of January, with the highest price reaching 1.98 and the lowest price hitting 1.94 during the day. NervGen Pharma appears to be dangerous, given 3 months investment horizon. NervGen Pharma Corp has Sharpe Ratio of 0.0574, which conveys that the firm had a 0.0574 % return per unit of risk over the last 3 months. We have found thirty technical indicators for NervGen Pharma, which you can use to evaluate the volatility of the firm. Please exercise NervGen Pharma's Risk Adjusted Performance of 0.0565, mean deviation of 3.53, and Downside Deviation of 5.17 to check out if our risk estimates are consistent with your expectations.
NervGen OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
NervGen |
Sharpe Ratio = 0.0574
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | NGENF | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
5.79 actual daily | 51 51% of assets are less volatile |
Expected Return
0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average NervGen Pharma is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NervGen Pharma by adding it to a well-diversified portfolio.
NervGen Pharma OTC Stock Price History Chart
There are several ways to analyze NervGen Stock price data. The simplest method is using a basic NervGen candlestick price chart, which shows NervGen Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 2, 2025 | 2.32 |
Lowest Price | November 15, 2024 | 1.46 |
NervGen Pharma January 31, 2025 OTC Stock Price Synopsis
Various analyses of NervGen Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell NervGen OTC Stock. It can be used to describe the percentage change in the price of NervGen Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of NervGen OTC Stock.NervGen Pharma Price Action Indicator | (0.01) | |
NervGen Pharma Price Rate Of Daily Change | 0.99 | |
NervGen Pharma Price Daily Balance Of Power | (0.25) |
NervGen Pharma January 31, 2025 OTC Stock Price Analysis
NervGen OTC Stock Price History Data
The price series of NervGen Pharma for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 has a statistical range of 0.86 with a coefficient of variation of 9.13. The daily prices for the period are spread out with arithmetic mean of 1.95. The median price for the last 90 days is 1.97.Open | High | Low | Close | Volume | ||
01/31/2025 | 1.98 | 1.98 | 1.94 | 1.96 | ||
01/29/2025 | 1.98 | 1.98 | 1.94 | 1.96 | 9,700 | |
01/28/2025 | 2.01 | 2.01 | 1.97 | 1.97 | 9,400 | |
01/27/2025 | 1.99 | 1.99 | 1.96 | 1.99 | 43,700 | |
01/24/2025 | 2.02 | 2.06 | 1.96 | 1.96 | 56,200 | |
01/23/2025 | 2.05 | 2.05 | 2.00 | 2.00 | 1,500 | |
01/22/2025 | 2.05 | 2.05 | 2.01 | 2.01 | 11,650 | |
01/21/2025 | 2.11 | 2.11 | 2.05 | 2.08 | 47,300 | |
01/17/2025 | 2.07 | 2.13 | 2.00 | 2.02 | 56,500 | |
01/16/2025 | 2.09 | 2.13 | 2.05 | 2.06 | 46,746 | |
01/15/2025 | 2.11 | 2.12 | 2.10 | 2.10 | 14,040 | |
01/14/2025 | 2.11 | 2.12 | 2.06 | 2.09 | 37,721 | |
01/13/2025 | 2.16 | 2.16 | 2.11 | 2.12 | 45,700 | |
01/10/2025 | 2.10 | 2.17 | 2.08 | 2.13 | 54,800 | |
01/08/2025 | 2.11 | 2.12 | 2.08 | 2.12 | 57,900 | |
01/07/2025 | 2.15 | 2.15 | 2.10 | 2.10 | 10,093 | |
01/06/2025 | 2.21 | 2.22 | 2.14 | 2.14 | 12,799 | |
01/03/2025 | 2.32 | 2.32 | 2.20 | 2.20 | 47,767 | |
01/02/2025 | 2.21 | 2.32 | 2.20 | 2.32 | 140,200 | |
12/31/2024 | 2.19 | 2.21 | 2.18 | 2.18 | 6,442 | |
12/30/2024 | 2.19 | 2.19 | 2.14 | 2.16 | 32,695 | |
12/27/2024 | 2.18 | 2.21 | 2.18 | 2.19 | 52,800 | |
12/26/2024 | 2.18 | 2.21 | 2.14 | 2.18 | 120,200 | |
12/24/2024 | 2.03 | 2.18 | 2.03 | 2.17 | 65,900 | |
12/23/2024 | 2.08 | 2.08 | 2.00 | 2.01 | 48,640 | |
12/20/2024 | 2.15 | 2.17 | 1.96 | 2.08 | 139,900 | |
12/19/2024 | 1.83 | 2.21 | 1.83 | 2.16 | 163,963 | |
12/18/2024 | 1.87 | 1.87 | 1.70 | 1.70 | 59,400 | |
12/17/2024 | 1.97 | 1.97 | 1.85 | 1.86 | 19,000 | |
12/16/2024 | 1.96 | 2.04 | 1.95 | 1.98 | 79,000 | |
12/13/2024 | 1.81 | 1.92 | 1.81 | 1.90 | 30,659 | |
12/12/2024 | 1.81 | 1.81 | 1.80 | 1.80 | 4,150 | |
12/11/2024 | 1.85 | 1.85 | 1.78 | 1.78 | 13,400 | |
12/10/2024 | 1.83 | 1.92 | 1.83 | 1.87 | 25,000 | |
12/09/2024 | 1.85 | 1.89 | 1.85 | 1.85 | 46,100 | |
12/06/2024 | 1.91 | 1.96 | 1.83 | 1.85 | 21,300 | |
12/05/2024 | 2.04 | 2.05 | 1.94 | 1.94 | 12,100 | |
12/04/2024 | 2.05 | 2.15 | 2.00 | 2.04 | 153,200 | |
12/03/2024 | 2.04 | 2.12 | 2.04 | 2.05 | 15,097 | |
12/02/2024 | 2.07 | 2.09 | 2.03 | 2.06 | 25,800 | |
11/29/2024 | 1.97 | 2.03 | 1.95 | 2.03 | 10,400 | |
11/27/2024 | 1.87 | 2.00 | 1.87 | 2.00 | 38,177 | |
11/26/2024 | 1.90 | 1.93 | 1.87 | 1.87 | 1,600 | |
11/25/2024 | 1.90 | 1.95 | 1.90 | 1.92 | 10,777 | |
11/22/2024 | 1.80 | 1.94 | 1.78 | 1.85 | 14,492 | |
11/21/2024 | 1.62 | 1.79 | 1.62 | 1.79 | 27,913 | |
11/20/2024 | 1.64 | 1.64 | 1.59 | 1.59 | 1,107 | |
11/19/2024 | 1.64 | 1.64 | 1.58 | 1.63 | 36,782 | |
11/18/2024 | 1.50 | 1.68 | 1.47 | 1.59 | 108,800 | |
11/15/2024 | 1.57 | 1.57 | 1.46 | 1.46 | 129,413 | |
11/14/2024 | 1.90 | 1.90 | 1.55 | 1.55 | 57,823 | |
11/13/2024 | 1.94 | 2.00 | 1.92 | 1.92 | 12,001 | |
11/12/2024 | 1.83 | 1.99 | 1.83 | 1.97 | 38,609 | |
11/11/2024 | 1.86 | 1.94 | 1.86 | 1.92 | 35,600 | |
11/08/2024 | 1.87 | 1.89 | 1.86 | 1.89 | 30,987 | |
11/07/2024 | 1.80 | 1.87 | 1.79 | 1.87 | 52,400 | |
11/06/2024 | 1.78 | 1.84 | 1.78 | 1.80 | 38,400 | |
11/05/2024 | 1.77 | 1.77 | 1.77 | 1.77 | 5,600 | |
11/04/2024 | 1.83 | 1.86 | 1.77 | 1.77 | 27,800 | |
11/01/2024 | 1.74 | 1.90 | 1.72 | 1.83 | 80,700 | |
10/31/2024 | 1.65 | 1.73 | 1.65 | 1.73 | 86,248 |
About NervGen Pharma OTC Stock history
NervGen Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NervGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NervGen Pharma Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NervGen Pharma stock prices may prove useful in developing a viable investing in NervGen Pharma
NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. NervGen Pharma Corp. was incorporated in 2017 and is based in Vancouver, Canada. NERVGEN PHARMA operates under Biotechnology classification in the United States and is traded on OTC Exchange.
NervGen Pharma OTC Stock Technical Analysis
NervGen Pharma technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
All Next | Launch Module |
NervGen Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NervGen Pharma's price direction in advance. Along with the technical and fundamental analysis of NervGen OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NervGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0565 | |||
Jensen Alpha | 0.1753 | |||
Total Risk Alpha | (0.30) | |||
Sortino Ratio | 0.0449 | |||
Treynor Ratio | 0.1973 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for NervGen OTC Stock analysis
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |